γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia

Leukemia

Volumn 27, Issue 6, 2013, Pages 1328-1338

  Scheper, W ^a   Van Dorp, S ^a   Kersting, S ^a   Pietersma, F ^a   Lindemans, C ^a   Hol, S ^a   Heijhuurs, S ^a   Sebestyen, Z ^a   Grunder C ^a   Marcu Malina, V ^a   Marchant, A ^b   Donner, C ^c   Plachter, B ^d   Vermijlen, D ^b   Van Baarle, D ^a   Kuball, J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

T cells; allogeneic stem cell transplantation; cytomegalovirus; leukemia; T cell receptor

Indexed keywords

CD8 ANTIGEN;

ADOPTIVE TRANSFER; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CELL INTERACTION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; DENDRITIC CELL; DISEASE ASSOCIATION; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS REACTIVATION;

CYTOMEGALOVIRUS; HUMANS; LEUKEMIA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; STEM CELL TRANSPLANTATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 84878908146     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.374     Document Type: Article

References (52)

1. Boeckh M, Geballe AP. Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest 2011; 121: 1673-1680.
2. Einsele H, Ehninger G, Hebart H, Weber P, Dette S, Link H et al. Incidence of local CMV infection and acute intestinal GVHD in marrow transplant recipients with severe diarrhoea. Bone Marrow Transplant 1994; 14: 955-963.
3. Takemoto Y, Takatsuka H, Wada H, Mori A, Saheki K, Okada M et al. Evaluation of CMV/human herpes virus-6 positivity in bronchoalveolar lavage fluids as early detection of acute GVHD following BMT: evidence of a significant relationship. Bone Marrow Transplant 2000; 26: 77-81. (Pubitemid 30456112)
4. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis 2002; 185: 273-282. (Pubitemid 34107239)
5. Behrendt CE, Rosenthal J, Bolotin E, Nakamura R, Zaia J, Forman SJ. Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy. Biol Blood Marrow Transplant 2009; 15: 54-60.
6. Elmaagacli AH, Steckel NK, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 2011; 118: 1402-1412.
7. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 2009; 22: 76-98.
8. Bonneville M, O'Brien RL, Born WK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 2010; 10: 467-478.
9. Constant P, Davodeau F, Peyrat MA, Poquet Y, Puzo G, Bonneville M et al. Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science 1994; 264: 267-270.
10. Gober HJ, Kistowska M, Angman L, Jeno P, Mori L, De LG. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 2003; 197: 163-168. (Pubitemid 36152311)
11. Bucy RP, Chen CL, Cooper MD. Tissue localization and CD8 accessory molecule expression of T gamma delta cells in humans. J Immunol 1989; 142: 3045-3049. (Pubitemid 19129920)
12. Deusch K, Luling F, Reich K, Classen M, Wagner H, Pfeffer K. A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment. Eur J Immunol 1991; 21: 1053-1059.
13. Dechanet J, Merville P, Lim A, Retiere C, Pitard V, Lafarge X et al. Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest 1999; 103: 1437-1449. (Pubitemid 29535500)
14. Knight A, Madrigal AJ, Grace S, Sivakumaran J, Kottaridis P, Mackinnon S et al. The role of Vdelta2-negative gammadelta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood 2010; 116: 2164-2172.
15. Pitard V, Roumanes D, Lafarge X, Couzi L, Garrigue I, Lafon ME et al. Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection. Blood 2008; 112: 1317-1324.
16. Puig-Pey I, Bohne F, Benitez C, Lopez M, Martinez-Llordella M, Oppenheimer F et al. Characterization of gammadelta T cell subsets in organ transplantation. Transpl Int 2010; 23: 1045-1055.
17. Vermijlen D, Brouwer M, Donner C, Liesnard C, Tackoen M, Van RM et al. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med 2010; 207: 807-821.
18. Lafarge X, Merville P, Cazin MC, Berge F, Potaux L, Moreau JF et al. Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role. J Infect Dis 2001; 184: 533-541. (Pubitemid 32783542)
19. Choudhary A, Davodeau F, Moreau A, Peyrat MA, Bonneville M, Jotereau F. Selective lysis of autologous tumor cells by recurrent gamma delta tumorinfiltrating lymphocytes from renal carcinoma. J Immunol 1995; 154: 3932-3940.
20. Ferrarini M, Heltai S, Pupa SM, Mernard S, Zocchi R. Killing of laminin receptorpositive human lung cancers by tumor infiltrating lymphocytes bearing gammadelta() t-cell receptors. J Natl Cancer Inst 1996; 88: 436-441.
21. Maeurer MJ, Martin D, Walter W, Liu K, Zitvogel L, Halusczcak K et al. Human intestinal Vdelta1 lymphocytes recognize tumor cells of epithelial origin. J Exp Med 1996; 183: 1681-1696. (Pubitemid 26134310)
22. Correia DV, Fogli M, Hudspeth K, da Silva MG, Mavilio D, Silva-Santos B. Differentiation of human peripheral blood Vdelta1 T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood 2011; 118: 992-1001.
23. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumorassociated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 1999; 96: 6879-6884. (Pubitemid 29274978)
24. Scotet E, Martinez LO, Grant E, Barbaras R, Jeno P, Guiraud M et al. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 2005; 22: 71-80. (Pubitemid 40143452)
25. van Dorp S, Pietersma F, Wolfl M, Verdonck LF, Petersen EJ, Lokhorst HM et al. Rituximab treatment before reduced-intensity conditioning transplantation associates with a decreased incidence of extensive chronic GVHD. Biol Blood Marrow Transplant 2009; 15: 671-678.
26. van Dorp S, Resemann H, te BL, Pietersma F, van BD, Gmelig-Meyling F et al. The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study. Haematologica 2011; 96: 1380-1384.
27. Riddell SR, Greenberg PD. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J Immunol Methods 1990; 128: 189-201. (Pubitemid 20120262)
28. Kuball J, Theobald M, Ferreira EA, Hess G, Burg J, Maccagno G et al. Control of organ transplant-associated graft-versus-host disease by activated host lymphocyte infusions. Transplantation 2004; 78: 1774-1779. (Pubitemid 40041644)
29. Marcu-Malina V, Heijhuurs S, van BM, Hartkamp L, Strand S, Sebestyen Z et al. Redirecting alphabeta T cells against cancer cells by transfer of a broadly tumor-reactive gammadeltaT-cell receptor. Blood 2011; 118: 50-59.
30. Allison TJ, Winter CC, Fournie JJ, Bonneville M, Garboczi DN. Structure of a human gammadelta T-cell antigen receptor. Nature 2001; 411: 820-824. (Pubitemid 32588108)
31. Kuball J, Dossett ML, Wolfl M, Ho WY, Voss RH, Fowler C et al. Facilitating matched pairing and expression of TCR chains introduced into human T cells. Blood 2007; 109: 2331-2338. (Pubitemid 46425872)
32. Stanislawski T, Voss RH, Lotz C, Sadovnikova E, Willemsen RA, Kuball J et al. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat Immunol 2001; 2: 962-970. (Pubitemid 32976170)
33. Couzi L, Levaillant Y, Jamai A, Pitard V, Lassalle R, Martin K et al. Cytomegalovirusinduced gammadelta T cells associate with reduced cancer risk after kidney transplantation. J Am Soc Nephrol 2010; 21: 181-188.
34. Halary F, Pitard V, Dlubek D, Krzysiek R, de la SH, Merville P et al. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells. J Exp Med 2005; 201: 1567-1578. (Pubitemid 40721002)
35. Leslie DS, Vincent MS, Spada FM, Das H, Sugita M, Morita CT et al. CD1-mediated gamma/delta T cell maturation of dendritic cells. J Exp Med 2002; 196: 1575-1584. (Pubitemid 36026469)
36. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997; 27: 3135-3142. (Pubitemid 28018007)
37. Kuball J, Schmitz FW, Voss RH, Ferreira EA, Engel R, Guillaume P et al. Cooperation of human tumor-reactive CD4 and CD8 T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR. Immunity 2005; 22: 117-129. (Pubitemid 40143456)
38. Das H, Groh V, Kuijl C, Sugita M, Morita CT, Spies T et al. MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity 2001; 15: 83-93. (Pubitemid 32728322)
39. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001; 2: 255-260. (Pubitemid 33706003)
40. Godder KT, Henslee-Downey PJ, Mehta J, Park BS, Chiang KY, Abhyankar S et al. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transplant 2007; 39: 751-757. (Pubitemid 46901973)
41. Willcox CR, Pitard V, Netzer S, Couzi L, Salim M, Silberzahn T et al. Cytomegalovirus and tumor stress surveillance by binding of a human gammadelta T cell antigen receptor to endothelial protein C receptor. Nat Immunol 2012; 13: 872-879.
42. Couzi L, Pitard V, Sicard X, Garrigue I, Hawchar O, Merville P et al. Antibody-dependent anti-cytomegalovirus activity of human gammadelta T cells expressing CD16 (FcgammaRIIIa). Blood 2012; 119: 1418-1427.
43. Cheroutre H. Starting at the beginning: new perspectives on the biology of mucosal T cells. Annu Rev Immunol 2004; 22: 217-246. (Pubitemid 38680423)
44. Cheroutre H, Lambolez F. Doubting the TCR coreceptor function of CD8alphaalpha. Immunity 2008; 28: 149-159. (Pubitemid 351215236)
45. Srour EF, Leemhuis T, Jenski L, Redmond R, Jansen J. Cytolytic activity of human natural killer cell subpopulations isolated by four-color immunofluorescence flow cytometric cell sorting. Cytometry 1990; 11: 442-446. (Pubitemid 20123084)
46. Addison EG, North J, Bakhsh I, Marden C, Haq S, Al-Sarraj S et al. Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity. Immunology 2005; 116: 354-361. (Pubitemid 41532126)
47. Lowdell MW, Ray N, Craston R, Corbett T, Deane M, Prentice HG. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia. Bone Marrow Transplant 1997; 19: 891-897. (Pubitemid 27217655)
48. Lowdell MW, Craston R, Samuel D, Wood ME, O'Neill E, Saha V et al. Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. Br J Haematol 2002; 117: 821-827. (Pubitemid 34639242)
49. Leishman AJ, Naidenko OV, Attinger A, Koning F, Lena CJ, Xiong Y et al. T cell responses modulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule, TL. Science 2001; 294: 1936-1939. (Pubitemid 33101592)
50. Feuchtinger T, Opherk K, Bethge WA, Topp MS, Schuster FR, Weissinger EM et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood 2010; 116: 4360-4367.
51. Leen AM, Myers GD, Sili U, Huls MH, Weiss H, Leung KS et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med 2006; 12: 1160-1166. (Pubitemid 44527351)
52. Ho WY, Nguyen HN, Wolfl M, Kuball J, Greenberg PD. In vitro methods for generating CD8 T-cell clones for immunotherapy from the naive repertoire. J Immunol Methods 2006; 310: 40-52. (Pubitemid 43375974)